Prostate Cancer Diagnoses Surge by 25% Post-Pandemic

The rise in cases highlights the impact of missed screenings during Covid-19, with late-stage diagnoses posing significant risks.

Prostate cancer cases in England increased by over 11,000 in 2022, marking a record 25% rise compared to the previous year.
Missed screenings during the Covid-19 pandemic led to later-stage diagnoses, where survival rates drop significantly.
Prostate cancer was the most affected by the pandemic, with an estimated 14,000 men missing diagnoses in 2020 and 2021.
NHS campaigns to encourage screenings post-pandemic have contributed to the higher diagnosis rates.
Despite the rise in diagnoses, cancer death rates in England have been declining, underscoring the importance of early detection.